HERON THERAPEUTICS, INC. /DE/ Increase (Decrease) in Accounts Payable
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Increase (Decrease) in Accounts Payable of $2.54 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $2.57M.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$24.00K, a 103.85% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$3.02M, a 298.75% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$20.00K.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for fiscal 2025 was -$2.71M, a 132.06% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for fiscal 2024 was $8.47M, a 56360.00% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for fiscal 2023 was $15.00K.
- HERON THERAPEUTICS, INC. /DE/ increase (decrease) in accounts payable for fiscal 2022 was -$578.00K, a 117.63% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $2.54M 10-Q · filed 2026-08-10 | -$478.00K derived: sum of 3 quarters · filed 2026-08-10 | -$498.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$24.00K 10-Q · filed 2026-05-11 | -$3.05M derived: sum of 2 quarters · filed 2026-05-11 | -$3.07M derived: sum of 3 quarters · filed 2026-05-11 | -$3.36M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.04M derived: sum of 2 quarters · filed 2026-02-26 | -$3.34M derived: sum of 3 quarters · filed 2026-08-10 | -$2.71M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$316.00K derived: sum of 2 quarters · filed 2026-08-10 | $308.00K 10-Q · filed 2025-11-04 | $1.83M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$296.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $328.00K 10-Q · filed 2026-08-10 | $1.85M derived: sum of 3 quarters · filed 2026-08-10 | $1.81M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $624.00K 10-Q · filed 2026-05-11 | $2.15M derived: sum of 2 quarters · filed 2026-05-11 | $2.11M derived: sum of 3 quarters · filed 2026-05-11 | $11.50M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.48M derived: sum of 2 quarters · filed 2026-02-26 | $10.87M derived: sum of 3 quarters · filed 2026-02-26 | $8.47M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $9.35M derived: sum of 2 quarters · filed 2025-11-04 | $6.95M 10-Q · filed 2025-11-04 | $8.33M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $9.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $6.99M 10-Q · filed 2025-08-08 | $8.37M derived: sum of 3 quarters · filed 2026-02-26 | $8.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$2.40M 10-Q · filed 2025-05-06 | -$1.02M derived: sum of 2 quarters · filed 2026-02-26 | -$1.12M derived: sum of 3 quarters · filed 2026-02-26 | -$3.23M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.28M derived: sum of 2 quarters · filed 2026-02-26 | -$825.00K derived: sum of 3 quarters · filed 2026-02-26 | $15.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.21M derived: sum of 2 quarters · filed 2024-11-12 | -$1.36M 10-Q · filed 2024-11-12 | -$4.69M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$2.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.27M 10-Q · filed 2024-08-06 | -$4.59M derived: sum of 3 quarters · filed 2025-02-27 | -$11.85M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $840.00K 10-Q · filed 2024-05-07 | -$2.48M derived: sum of 2 quarters · filed 2025-02-27 | -$9.74M derived: sum of 3 quarters · filed 2025-02-27 | -$4.16M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$10.58M derived: sum of 2 quarters · filed 2025-02-27 | -$5.00M derived: sum of 3 quarters · filed 2025-02-27 | -$578.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | -$7.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.68M derived: sum of 2 quarters · filed 2023-11-14 | $2.74M 10-Q · filed 2023-11-14 | $662.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $5.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $10.00M 10-Q · filed 2023-08-14 | $7.92M derived: sum of 3 quarters · filed 2023-08-14 | $2.56M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $4.42M 10-Q · filed 2023-05-11 | $2.34M derived: sum of 2 quarters · filed 2023-05-11 | -$3.02M derived: sum of 3 quarters · filed 2023-05-11 | $6.54M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$7.44M derived: sum of 2 quarters · filed 2023-03-29 | $2.11M derived: sum of 3 quarters · filed 2023-03-29 | $3.28M 10-K · filed 2023-03-29 |
| 2021-09-30 | -$5.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.20M derived: sum of 2 quarters · filed 2022-11-08 | $5.36M 10-Q · filed 2022-11-08 | -$6.18M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $9.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $10.72M 10-Q · filed 2022-08-09 | -$825.00K derived: sum of 3 quarters · filed 2022-08-09 | -$7.22M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $1.16M 10-Q · filed 2022-05-09 | -$10.38M derived: sum of 2 quarters · filed 2022-05-09 | -$16.77M derived: sum of 3 quarters · filed 2022-05-09 | -$9.87M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$11.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$17.93M derived: sum of 2 quarters · filed 2022-02-28 | -$11.04M derived: sum of 3 quarters · filed 2022-02-28 | -$2.23M 10-K · filed 2022-02-28 |
| 2020-09-30 | -$6.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $505.00K derived: sum of 2 quarters · filed 2021-11-03 | $9.31M 10-Q · filed 2021-11-03 | $10.44M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $6.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $15.70M 10-Q · filed 2021-08-09 | $16.83M derived: sum of 3 quarters · filed 2022-02-28 | $10.46M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $8.80M 10-Q · filed 2021-05-10 | $9.94M derived: sum of 2 quarters · filed 2022-02-28 | $3.56M derived: sum of 3 quarters · filed 2022-02-28 | $751.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$5.24M derived: sum of 2 quarters · filed 2022-02-28 | -$8.05M derived: sum of 3 quarters · filed 2022-02-28 | -$14.11M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$6.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$9.18M derived: sum of 2 quarters · filed 2020-11-05 | -$15.24M 10-Q · filed 2020-11-05 | -$8.02M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$2.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$8.87M 10-Q · filed 2020-08-05 | -$1.65M derived: sum of 3 quarters · filed 2021-02-24 | $3.02M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$6.05M 10-Q · filed 2020-05-06 | $1.17M derived: sum of 2 quarters · filed 2021-02-24 | $5.83M derived: sum of 3 quarters · filed 2021-02-24 | -$647.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $7.22M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $11.88M derived: sum of 2 quarters · filed 2021-02-24 | $5.41M derived: sum of 3 quarters · filed 2021-02-24 | -$1.91M 10-K · filed 2021-02-24 |
| 2018-09-30 | $4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$1.81M derived: sum of 2 quarters · filed 2019-11-12 | -$9.13M 10-Q · filed 2019-11-12 | $4.31M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$13.79M 10-Q · filed 2019-08-05 | -$358.00K derived: sum of 3 quarters · filed 2020-03-02 | -$1.34M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$7.31M 10-Q · filed 2019-05-09 | $6.12M derived: sum of 2 quarters · filed 2020-03-02 | $5.14M derived: sum of 3 quarters · filed 2020-03-02 | $6.98M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $13.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $12.45M derived: sum of 2 quarters · filed 2020-03-02 | $14.29M derived: sum of 3 quarters · filed 2020-03-02 | $11.96M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$978.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $860.00K derived: sum of 2 quarters · filed 2018-11-07 | -$1.48M 10-Q · filed 2018-11-07 | -$753.00K derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $1.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$499.00K 10-Q · filed 2018-08-08 | $225.00K derived: sum of 3 quarters · filed 2019-02-22 | -$2.35M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$2.34M 10-Q · filed 2018-05-10 | -$1.61M derived: sum of 2 quarters · filed 2019-02-22 | -$4.18M derived: sum of 3 quarters · filed 2019-02-22 | -$2.38M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $724.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$1.85M derived: sum of 2 quarters · filed 2019-02-22 | -$47.00K derived: sum of 3 quarters · filed 2019-02-22 | $3.51M 10-K · filed 2019-02-22 |
| 2016-09-30 | -$2.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$771.00K derived: sum of 2 quarters · filed 2017-11-06 | $2.79M 10-Q · filed 2017-11-06 | $3.35M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $5.36M 10-Q · filed 2017-08-09 | $5.93M derived: sum of 3 quarters · filed 2018-02-27 | $5.67M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $3.56M 10-Q · filed 2017-05-10 | $4.13M derived: sum of 2 quarters · filed 2018-02-27 | $3.87M derived: sum of 3 quarters · filed 2018-02-27 | $4.48M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $565.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $313.00K derived: sum of 2 quarters · filed 2018-02-27 | $917.00K derived: sum of 3 quarters · filed 2018-02-27 | $751.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | -$252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $352.00K derived: sum of 2 quarters · filed 2016-11-08 | $186.00K 10-Q · filed 2016-11-08 | $1.26M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $604.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $438.00K 10-Q · filed 2016-08-08 | $1.51M derived: sum of 3 quarters · filed 2017-02-23 | $1.22M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$166.00K 10-Q · filed 2016-05-05 | $908.00K derived: sum of 2 quarters · filed 2017-02-23 | $614.00K derived: sum of 3 quarters · filed 2017-02-23 | -$1.12M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $780.00K derived: sum of 2 quarters · filed 2017-02-23 | -$953.00K derived: sum of 3 quarters · filed 2017-02-23 | $1.28M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$2.03M derived: sum of 2 quarters · filed 2015-11-06 | $211.00K 10-Q · filed 2015-11-06 | -$729.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $505.00K 10-Q · filed 2015-08-07 | -$435.00K derived: sum of 3 quarters · filed 2016-02-19 | -$2.77M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | $2.24M 10-Q · filed 2015-05-08 | $1.30M derived: sum of 2 quarters · filed 2016-02-19 | -$1.04M derived: sum of 3 quarters · filed 2016-02-19 | $482.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$940.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$3.27M derived: sum of 2 quarters · filed 2016-02-19 | -$1.76M derived: sum of 3 quarters · filed 2016-02-19 | -$426.00K 10-K · filed 2016-02-19 |
| 2013-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$816.00K derived: sum of 2 quarters · filed 2014-11-06 | $514.00K 10-Q · filed 2014-11-06 | $518.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | $1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $2.85M 10-Q · filed 2014-08-04 | $2.85M derived: sum of 3 quarters · filed 2015-03-13 | $3.91M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | $1.33M 10-Q · filed 2014-05-12 | $1.33M derived: sum of 2 quarters · filed 2015-03-13 | $2.39M derived: sum of 3 quarters · filed 2015-03-13 | $2.12M derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | $1.06M derived: sum of 2 quarters · filed 2015-03-13 | $786.00K derived: sum of 3 quarters · filed 2015-03-13 | $984.00K 10-K · filed 2015-03-13 |
| 2012-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $782.00K derived: sum of 2 quarters · filed 2013-11-12 | $980.00K 10-Q · filed 2013-11-12 | $1.17M derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$272.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$74.00K 10-Q · filed 2013-08-08 | $119.00K derived: sum of 3 quarters · filed 2014-03-07 | $263.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $198.00K 10-Q · filed 2013-05-10 | $391.00K derived: sum of 2 quarters · filed 2014-03-07 | $535.00K derived: sum of 3 quarters · filed 2014-03-07 | $515.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2011-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $337.00K derived: sum of 2 quarters · filed 2014-03-07 | $317.00K derived: sum of 3 quarters · filed 2014-03-07 | $467.00K 10-K · filed 2014-03-07 |
| 2011-09-30 | $144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-05 | $124.00K derived: sum of 2 quarters · filed 2012-11-05 | $274.00K 10-Q · filed 2012-11-05 | $276.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $130.00K 10-Q · filed 2012-08-09 | $132.00K derived: sum of 3 quarters · filed 2013-03-01 | $161.00K derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $150.00K 10-Q · filed 2012-05-10 | $152.00K derived: sum of 2 quarters · filed 2013-03-01 | $181.00K derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $31.00K derived: sum of 2 quarters · filed 2013-03-01 | -$3.00K 10-K · filed 2013-03-01 | |
| 2010-09-30 | $29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$5.00K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$34.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | -$182.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |